Some of the best links we picked up around the internet
As 2023 draws to a close, we look back on some of the major clinical highlights from the year gone by.
There are currently four clinical-stage gene-editing candidates in clinical trials for sickle cell disease, which affects millions of people worldwide...
In this roundup, we provide a summary of the ongoing gene-editing trials for beta thalassemia. This update includes trials sponsored by Vertex...
This week's clinical update summarises data shared at the recent European Hematology Congress (EHA2022). The updates include positive data from...